- English (USA)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
GlaxoSmithKline Pakistan Ltd (GLAX)
Track today's live GlaxoSmithKline Pakistan (GLAX) share price, performance and key data on this page with our current Karachi:GLAX stock exchange information. Analyse interactive charts and historical data, check technical buy and sell signals in real time, and follow the GlaxoSmithKline Pakistan share price on the Karachi exchange. Use the dropdown to switch exchange for the GLAX share price, head to our technical summary section, which provides analysis on GlaxoSmithKline Pakistan share price buy/sell indicators using real-time data (or discuss the GlaxoSmithKline Pakistan (GLAX) stock price today with other investors in the GlaxoSmithKline Pakistan PSX share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current PSX:GLAX share price (ISIN: PK0001301016) to enhance your trading decisions with our free investment tools and resources.
What Is the GlaxoSmithKline Pakistan Ltd Share Price Today?
The GlaxoSmithKline Pakistan share price today is 341.39.
What Is the Stock Symbol for GlaxoSmithKline Pakistan Ltd
The stock symbol (or 'ticker') for GlaxoSmithKline Pakistan Ltd is "GLAX."
What Stock Exchange Does GlaxoSmithKline Pakistan Ltd Trade On?
GlaxoSmithKline Pakistan Ltd is listed and trades on the Karachi stock exchange.
Is GlaxoSmithKline Pakistan Ltd a Good Stock to Buy?
Determining whether GlaxoSmithKline Pakistan (or any stock) is a good buy requires comprehensive market analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and more than 1,200 other metrics.
Use the dropdown to select a relevant stock exchange for the current PSX:GLAX share price (ISIN: PK0001301016) to enhance your trading decisions with our free investment tools and resources.
What Is the GlaxoSmithKline Pakistan Ltd Share Price Today?
The GlaxoSmithKline Pakistan share price today is 341.39.
What Is the Stock Symbol for GlaxoSmithKline Pakistan Ltd
The stock symbol (or 'ticker') for GlaxoSmithKline Pakistan Ltd is "GLAX."
What Stock Exchange Does GlaxoSmithKline Pakistan Ltd Trade On?
GlaxoSmithKline Pakistan Ltd is listed and trades on the Karachi stock exchange.
Is GlaxoSmithKline Pakistan Ltd a Good Stock to Buy?
Determining whether GlaxoSmithKline Pakistan (or any stock) is a good buy requires comprehensive market analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and more than 1,200 other metrics.
341.39
+4.08(+1.21%)
Delayed Data·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
339.40
343.00
52 wk Range
293.09
459.27
Earnings results expected today
1/3
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
339.40343.00
52 wk Range
293.09459.27
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
GLAX Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Analysts Sentiment
Strong Buy
Price Target
510.00
Upside
+49.39%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Trading at a low earnings multiple
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Buy
Analyst Ratings
3 Buy
0 Hold
0 Sell
Ratings:
3 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 510.00
(+49.39% Upside)
Earnings
Latest Release
24/08/2026
EPS / Forecast
6.19 / --
Revenue / Forecast
14.49B / --
Compare GLAX to Peers and Sector
Metrics to compare | GLAX | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipGLAXPeersSector | |
|---|---|---|---|---|
P/E Ratio | 9.8x | 17.4x | −0.2x | |
PEG Ratio | 0.50 | 0.13 | 0.00 | |
Price/Book | 3.1x | 3.0x | 2.6x | |
Price / LTM Sales | 1.5x | 1.6x | 2.8x | |
Upside (Analyst Target) | 49.7% | 16.1% | 60.9% | |
Fair Value Upside | Unlock | 13.1% | 9.5% | Unlock |
GlaxoSmithKline Pakistan Limited, a biopharma company, engages in the discovery, development, and delivery of medicines and vaccines in Pakistan. It offers products in the anti-infective, dermatology, respiratory, immunology and inflammation, oncology, infectious diseases, HIV, and vaccines therapy areas. The company sells its products under the Augmentin, Velosef, Amoxil, Dermovate, Clobevate, Betnovate, Calpol, Shingrix, and Cutivate brands. It also exports its products. The company was founded in 2001 and is headquartered in Karachi, Pakistan. GlaxoSmithKline Pakistan Limited operates as a subsidiary of GSK plc.
Ownership
Ownership Overview
Top Holders
People Also Watch
FAQ
What Is the GlaxoSmithKline Pakistan (Karachi: GLAX) Share Price Today?
The GlaxoSmithKline Pakistan stock price today is 341.39 PKR.
What Stock Exchange Does GlaxoSmithKline Pakistan (GLAX) Trade On?
GlaxoSmithKline Pakistan is listed and trades on the Karachi Stock Exchange.
What Is the Ticker (Stock Symbol) for GlaxoSmithKline Pakistan?
The stock symbol (also called a 'ticker') for GlaxoSmithKline Pakistan is "GLAX."
Does GlaxoSmithKline Pakistan Pay Dividends? What’s The Current GLAX Dividend Yield?
Yes, GLAX Pays Dividends to its Shareholders. The current GlaxoSmithKline Pakistan dividend yield is 5.6%%.
What Is the Current GlaxoSmithKline Pakistan Market Capitalisation?
As of today, GlaxoSmithKline Pakistan (Karachi: GLAX) market cap is 108.72B PKR.
What Is GlaxoSmithKline Pakistan's (GLAX) Earnings Per Share (TTM)?
The GlaxoSmithKline Pakistan EPS is currently 34.49 (Trailing Twelve Months).
When Is the Next GlaxoSmithKline Pakistan Earnings Date?
GlaxoSmithKline Pakistan's next earnings report will be released on 10/11/2026.
Is GLAX a Buy or Sell From a Technical Analyst Perspective?
Based on today's GlaxoSmithKline Pakistan moving averages and other technical indicators, the daily buy/sell signal for GLAX stock is Strong Buy.
How Many Times Has GlaxoSmithKline Pakistan Stock Split?
GlaxoSmithKline Pakistan has split 9 times. (See the GLAX stock split history page for full effective split date and price information.)
How Many Employees Does GlaxoSmithKline Pakistan Have?
GlaxoSmithKline Pakistan has 1606 employees, based on their latest Companies House report.
What is the current trading status of GlaxoSmithKline Pakistan (Karachi: GLAX)?
As of 10/11/2026, GlaxoSmithKline Pakistan (GLAX) is trading at a share price of 341.39 PKR, with a previous close of 337.31 PKR. The stock has fluctuated within a day range of 339.40 PKR to 343.00 PKR, while its 52-week range spans from 293.09 PKR to 459.27 PKR.
What Is GlaxoSmithKline Pakistan (GLAX) Price Target According to Analysts?
The average 12-month price target for GlaxoSmithKline Pakistan is 510.00 PKR, with a high estimate of 510 PKR and a low estimate of 510 PKR. 3 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +49.39% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.